Difference between revisions of "Team:ETH Zurich/Safety"
Line 70: | Line 70: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/d/d5/RiskD1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
Line 95: | Line 97: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/d/df/RiskB1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><b>I spilled and entire bottle of ethidium bromide on my lab coat!</b></td> | <td><b>I spilled and entire bottle of ethidium bromide on my lab coat!</b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/7/78/RiskD4.png" width="70%"> | ||
+ | </td> | ||
<td> | <td> | ||
<ul> | <ul> | ||
Line 112: | Line 118: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/5/55/RiskC1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
Line 118: | Line 126: | ||
<tr> | <tr> | ||
<td><b>I forgot to put my goggles on and now I have sulphuric acid in my eye!</b></td> | <td><b>I forgot to put my goggles on and now I have sulphuric acid in my eye!</b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/d/da/RiskC5.png" width="70%"> | ||
+ | </td> | ||
<td> | <td> | ||
<ul> | <ul> | ||
Line 130: | Line 140: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/d/df/RiskB1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
Line 146: | Line 158: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/d/d5/RiskD1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
Line 169: | Line 183: | ||
<tr> | <tr> | ||
<td><b>E.coli infection</b></td> | <td><b>E.coli infection</b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/7/75/RiskD3.png" width="70%"> | ||
+ | </td> | ||
<td> | <td> | ||
<ul> | <ul> | ||
Line 179: | Line 195: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/d/df/RiskB1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><b>E.coli released into environment</b></td> | <td><b>E.coli released into environment</b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/b/b4/RiskB5.png" width="70%"> | ||
+ | </td> | ||
<td> | <td> | ||
<ul> | <ul> | ||
Line 194: | Line 214: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/d/df/RiskB1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
Line 230: | Line 252: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/5/55/RiskC1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><b>False positive test result</b></td> | <td><b>False positive test result</b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/7/78/RiskD4.png" width="70%"> | ||
+ | </td> | ||
<td> | <td> | ||
<ul> | <ul> | ||
Line 248: | Line 274: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/5/55/RiskC1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><b>Production error</b></td> | <td><b>Production error</b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/b/bc/RiskD5.png" width="70%"> | ||
+ | </td> | ||
<td> | <td> | ||
<ul> | <ul> | ||
Line 266: | Line 296: | ||
</li> | </li> | ||
</b></td> | </b></td> | ||
− | <td>< | + | <td> |
+ | <img src="https://static.igem.org/mediawiki/2015/d/df/RiskB1.png" width="70%"> | ||
+ | </td> | ||
</tr> | </tr> | ||
</table> | </table> |
Revision as of 23:49, 18 September 2015
- Project
- Modeling
- Lab
- Human
Practices - Parts
- About Us
General Safety Considerations
Method of Safety evaluation
To manage the risks associated with our MicroBeacon CTC detection system we used the following scheme to evaluate possible adverse scenarios and the effectiveness of countermeasures:
Preventive measures can either serve to decrease the likelihood (x-axis) or the severity (y-axis) of a potential scenario or both.
Working at the ETH Zurich labs
Responsible conduct during everyday lab hours is parmount for the prevention of accidents. Every new person in the ETH D-BSSE lab must undergo safety training instructed by a Technical Manager. No exception was made for our iGEM team. Though much of it is common sense and our work was restricted to Biosafety Level 1, there is still a lot that can go wrong. Here are a few examples:
Possible Scenario | Risk | Countermeasures | Improved Risk |
Accidental poisoning |
|
||
My E. coli are on fire! |
Since we use Bunsen burners to create a semi-sterile working environment it is quite likely that something catches fire. |
||
I spilled and entire bottle of ethidium bromide on my lab coat! |
|
||
I forgot to put my goggles on and now I have sulphuric acid in my eye! |
|
||
Dangerous equipment |
|
Handling genetically modified organisms
Since our MicroBeacon E. coli cells are genetically modified they might harbor a potential and unforseen risk to the environment. However, our MicroBeacons do not express any toxic substances and the fact that they prefer temperatures around 37 °C makes it unlikely that they survive for a long time when accidentally released. We originally planned to have the MicroBeacons express TRAIL as a means to induce apoptosis in targeted cells. However, wie decided against this in order to minimize any potential health hazard.
Possible Scenario | Risk | Countermeasures | Improved Risk |
E.coli infection |
|
||
E.coli released into environment |
|
Using our MicroBeacon CTC detection system for medical diagnosis
It is never too early to think ahead what might happen if our MicroBeacon project is further developed and commercially used as a cancer diagnosis kit. Since one component of the kit are live bacteria, one must be especially careful in a clinical environment. Cancer patients may have a compromised immune system already.
Possible Scenario | Risk | Countermeasures | Improved Risk |
E.coli infection |
|
||
False positive test result |
Consider the ethical implications of diagnosing cancer metastasis in a healthy individual. |
||
Production error |
On the side of the manufacturer: consider the finanial risk and possible damage to the company's reputation |